PK

Pawan Kumar Suri

Active Director Managing Director DIN 08481004
DIN 08481004 First appointment Jul 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Jul 2019
Shareholding value •••• Premium profile

About Pawan Kumar Suri

Data last updated:

Pawan Kumar Suri is a Managing Director at Pharmalex India Private Limited (since 2019) and Director at Cunesoft India Private Limited (since 2023). The companies operate in Healthcare and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹90.01 Cr; the largest is Pharmalex India Private Limited at ₹74.75 Cr (FY 2025).

DIN 08481004
Primary Designation Managing Director
Industry Healthcare
First Appointment 01 Jul 2019
Oldest Company Age 13 yrs
Largest company Pharmalex India Private Limited · ₹74.75 Cr (FY 2025)
Combined revenue ₹90.01 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmalex India Private Limited U85100DL2013FTC252553
Managing Director01 Jul 20192013₹74.75 Cr (FY 2025)Active
Cunesoft India Private Limited U72200KA2016PTC093318
Director29 Aug 20232016₹15.26 Cr (FY 2024)Active

Board colleagues of Pawan Kumar Suri

Directorship timeline

Open interactive timeline →
Cunesoft India Private Limited
Pharmalex India Private Limited
Premium access

Shareholding and investment profile for Pawan Kumar Suri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Kumar Suri

Pawan Kumar Suri currently holds 2 directorships: Pharmalex India Private Limited (Managing Director, since 01 Jul 2019, revenue ₹74.75 Cr (FY 2025)); Cunesoft India Private Limited (Director, since 29 Aug 2023, revenue ₹15.26 Cr (FY 2024)).

Pawan Kumar Suri was first appointed on 01 Jul 2019 as Managing Director at Pharmalex India Private Limited. The most recent appointment on record is 29 Aug 2023 at Cunesoft India Private Limited.

The 2 current companies of Pawan Kumar Suri that report revenue have a combined latest revenue of ₹90.01 Cr: Pharmalex India Private Limited ₹74.75 Cr (FY 2025); Cunesoft India Private Limited ₹15.26 Cr (FY 2024).

The current boards of Pawan Kumar Suri's companies include Christopher . Gauglitz (Pharmalex India Private Limited), Rajendra Prasad Hanumanthaiah (Cunesoft India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available